JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Axcelis
ACLS
$4.39B
| $14.4M | ﹤0.01% |
108,160
-729
| -0.7% | -$85.6K |
2015 Q4
29 quarters
|
|
1877
TriNet
TNET
$2.93B
| $14.4M | ﹤0.01% |
178,780
-5,150
| -3% | -$403K |
2014 Q2
35 quarters
|
|
1878
Vipshop
VIPS
$6.04B
| $14.4M | ﹤0.01% |
948,316
+815,299
| +613% | +$12.1M |
2013 Q3
38 quarters
|
|
1879
Constellium
CSTM
$3.43B
| $14.4M | ﹤0.01% |
941,784
+76,952
| +9% | +$1.12M |
2022 Q1
4 quarters
|
|
1880
Dolby
DLB
$5.56B
| $14.4M | ﹤0.01% |
167,998
+40,864
| +32% | +$3.3M |
2015 Q4
29 quarters
|
|
1881
Information Services Group
III
$282M
| $14.3M | ﹤0.01% |
2,813,538
-105,967
| -4% | -$544K |
2017 Q4
21 quarters
|
|
1882
PUT
Oracle
ORCL
$432B
| $14.3M | ﹤0.01% |
154,000
-49,900
| -24% | -$4.38M |
2015 Q3
30 quarters
|
|
1883
CALL
Voya Financial
VOYA
$8.89B
| $14.3M | ﹤0.01% |
+200,000
| New | +$14M |
2023 Q1
0 quarters
|
|
1884
PUT
Caterpillar
CAT
$390B
| $14.3M | ﹤0.01% |
62,400
-109,800
| -64% | -$26.5M |
2013 Q2
39 quarters
|
|
1885
Descartes Systems
DSGX
$6.9B
| $14.2M | ﹤0.01% |
176,468
+27,295
| +18% | +$2.03M |
2015 Q4
29 quarters
|
|
1886
Visteon
VC
$2.38B
| $14.2M | ﹤0.01% |
90,565
+16,377
| +22% | +$2.53M |
2013 Q2
39 quarters
|
|
|
GRFS
1887
Grifois
GRFS
$5.04B
| $14.2M | ﹤0.01% |
1,923,501
+342,912
| +22% | +$2.97M |
2013 Q2
39 quarters
|
|
|
SLY
1888
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $14.2M | ﹤0.01% |
168,595
+47,081
| +39% | +$4.08M |
2018 Q4
17 quarters
|
|
1889
Community Health Systems
CYH
$389M
| $14.2M | ﹤0.01% |
2,887,785
+2,813,728
| +3,799% | +$14.8M |
2013 Q2
39 quarters
|
|
1890
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.1B
| $14.1M | ﹤0.01% |
226,277
-154,237
| -41% | -$9.48M |
2017 Q1
24 quarters
|
|
1891
Rocket Pharmaceuticals
RCKT
$287M
| $14.1M | ﹤0.01% |
821,275
-26,046
| -3% | -$510K |
2018 Q2
19 quarters
|
|
1892
Banco Bradesco
BBD
$45.9B
| $14.1M | ﹤0.01% |
5,363,625
-306,118
| -5% | -$814K |
2013 Q2
39 quarters
|
|
1893
Sociedad Química y Minera de Chile
SQM
$18.8B
| $14M | ﹤0.01% |
172,724
+24,314
| +16% | +$2.09M |
2014 Q1
36 quarters
|
|
1894
Pacific Biosciences
PACB
$892M
| $14M | ﹤0.01% |
1,208,876
+392,455
| +48% | +$3.9M |
2017 Q4
21 quarters
|
|
1895
UiPath
PATH
$6.86B
| $14M | ﹤0.01% |
797,003
+446,751
| +128% | +$6.75M |
2021 Q2
7 quarters
|
|
1896
Kohl's
KSS
$2.21B
| $14M | ﹤0.01% |
594,397
-1,546,981
| -72% | -$43.6M |
2013 Q2
39 quarters
|
|
1897
New Mountain Finance
NMFC
$647M
| $14M | ﹤0.01% |
1,148,529
+28,871
| +3% | +$363K |
2015 Q4
29 quarters
|
|
1898
Mattel
MAT
$4.59B
| $14M | ﹤0.01% |
759,075
+85,493
| +13% | +$1.59M |
2013 Q2
39 quarters
|
|
1899
PUT
Nike
NKE
$50.4B
| $14M | ﹤0.01% |
113,800
-47,600
| -29% | -$5.85M |
2016 Q1
28 quarters
|
|
1900
GXO Logistics
GXO
$5.27B
| $13.9M | ﹤0.01% |
276,331
-94,530
| -25% | -$4.7M |
2021 Q3
6 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.